NCATS will fund up to $500,000 per year for projects that support testing new therapeutic uses for experimental drugs across a broad range of pediatric diseases. This innovative program allows investigators to propose new therapeutic uses for drugs from pharmaceutical company partners. Strong applications will include scientific evidence that your drug repurposing will have a positive impact on the disease/condition.

Learn more and submit your letter of intent here.